Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	52.23	10.72	29.47	19.38	9.95
Short-Term Investments	7.5	2.41	1.51	1.08	1.09
Trading Asset Securities	-	8.08	3.08	0.58	0.58
Cash & Short-Term Investments	59.73	21.21	34.05	21.04	11.62
Cash Growth	181.69%	-37.73%	61.84%	81.16%	-62.41%
Accounts Receivable	1,771	648.49	345.6	902.73	410.75
Other Receivables	-	-	-	0.16	0.18
Receivables	1,776	650.95	347.11	903.79	418.19
Inventory	2,399	1,750	1,501	464.6	675.75
Restricted Cash	-	0.38	3.38	0.26	0.25
Other Current Assets	45.02	149.49	276.34	136.81	195.01
Total Current Assets	4,280	2,572	2,162	1,526	1,301
Property, Plant & Equipment	524.89	461.53	386.26	322.82	303.25
Long-Term Investments	7.53	4.66	0.03	0.03	0.03
Other Intangible Assets	4.27	4.2	3.08	0.56	0.27
Other Long-Term Assets	57.87	33.61	21.32	19.98	11.83
Total Assets	4,874	3,076	2,573	1,870	1,616
Accounts Payable	1,448	629.47	593.43	486.17	599.61
Accrued Expenses	-	27.98	27.47	24.45	20.53
Short-Term Debt	-	867.6	677.09	186.19	167.37
Current Portion of Long-Term Debt	1,506	59.52	33.98	-	-
Current Income Taxes Payable	71.16	55.35	42.9	27.91	11.26
Other Current Liabilities	186.83	28.36	21.7	12.79	65.8
Total Current Liabilities	3,212	1,668	1,397	737.5	864.56
Long-Term Debt	165.35	127.98	154.4	420.39	291.11
Long-Term Deferred Tax Liabilities	44.84	41.37	38.43	14.31	13.77
Other Long-Term Liabilities	38.33	12.04	9.67	7.05	6.04
Total Liabilities	3,460	1,861	1,609	1,189	1,185
Common Stock	47.22	46.99	45.32	44.33	39.9
Additional Paid-In Capital	-	714.27	549.69	454.12	271.55
Retained Earnings	-	437.73	285.48	180.04	119.26
Comprehensive Income & Other	1,367	15.72	83.27	2.13	-
Total Common Equity	1,414	1,215	963.76	680.61	430.7
Shareholders' Equity	1,414	1,215	963.76	680.61	430.7
Total Liabilities & Equity	4,874	3,076	2,573	1,870	1,616
Total Debt	1,671	1,055	865.47	606.59	458.48
Net Cash (Debt)	-1,612	-1,034	-831.41	-585.54	-446.87
Net Cash Per Share	-366.04	-222.73	-185.67	-141.03	-112.00
Filing Date Shares Outstanding	4.4	4.7	4.53	4.43	3.99
Total Common Shares Outstanding	4.4	4.7	4.53	4.43	3.99
Working Capital	1,068	903.72	765.54	788.99	436.25
Book Value Per Share	321.09	258.50	212.64	153.54	107.96
Tangible Book Value	1,410	1,211	960.68	680.05	430.43
Tangible Book Value Per Share	320.12	257.60	211.96	153.42	107.89
Land	-	5.24	5.24	5.24	5.24
Buildings	-	220.93	210.02	210.02	200.76
Machinery	-	391.07	289.59	198.63	167.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.